Immunotherapies for the Treatment of Uveal Melanoma—History and Future

por Schank, Timo E., Hassel, Jessica C.
Publicado 2019

Quality of life, treatment satisfaction and efficacy of non-biological systemic therapies in patients with plaque psoriasis: study protocol for a prospective observational study

por Fink, Christine, Schank, Timo E, Trenkler, Nina, Uhlmann, Lorenz, Schäkel, Knut
Publicado 2017

Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients

por Machiraju, Devayani, Wiecken, Melanie, Lang, Nina, Hülsmeyer, Ingrid, Roth, Jasmin, Schank, Timo E., Eurich, Rosa, Halama, Niels, Enk, Alexander, Hassel, Jessica C.
Publicado 2021

Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free Survival

por Schank, Timo E., Forschner, Andrea, Sachse, Michael Max, Dimitrakopoulou-Strauss, Antonia, Sachpekidis, Christos, Stenzinger, Albrecht, Volckmar, Anna-Lena, Enk, Alexander, Hassel, Jessica C.
Publicado 2021

Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA)

por Hassel, Jessica C., Schank, Timo E., Smetak, Heiko, Mühlbauer, Jasmin, Salzmann, Martin, Machiraju, Devayani, Menzer, Christian, Lang, Kristin, König, Laila, Haefner, Matthias F., Hülsmeyer, Ingrid, Kohler, Christian, Spang, Rainer, Enk, Alexander, Debus, Jürgen, Beckhove, Philipp
Publicado 2022